Kambo Science

Studies on Kambo began in the 1930's, but the first discovery of biopeptides didn't occur until 1966. Scientific research began in 1980 with Italian pharmacologist Vittorio Erspamer of the University of Rome.

He was nominated twice for the Nobel Prize and is considered to be the first scientist to analyze Kambo in the laboratory, concluding that Kambo contains a "fantastic chemical cocktail with potential medical applications unmatched by any other amphibian."

Since 1966 there have been more than 70 Kambo patents registered.

Each isolated peptide plays a different role in cellular messaging and regeneration. Peptides are signaling agents found in every cell and tissue, and are essential to achieve homeostasis, repair damaged cells, and maintain overall good health and well being. 

The medical paradigm we have been under for decades is a disease killing one,

which can also damage other cells in the body along with the disease.

Peptide therapy can help cells operate to prevent disease and work harmoniously with the body's cellular structure.

Peptides target specific cells without causing toxicity to surrounding healthy cells.

They are recognized and tolerated by the body, promoting healthier cellular function. 

On a cellular level, peptides function in the following capacity: 

• Modulate appropriate inflammatory response

• Assist in cellular autophagy, mitophagy, and apoptosis

• Optimize mitochondrial function

• Reestablish or protect cellular efficiency

• reestablish or maintain cell metabolic flexibility

• Maintain nucleotide cofactor ratios of NAD+/NADH, NADP+/NADPH,

       acetyl CoA/CoA and ADP/ATP to maintain ultimate cellular redox

• Optimize P53, SIRT, and FOXO genes

• Monitor and influence timing of cellular senescence

• Reverse or inhibit epigenetic influences of the genome

Private Kambo Ceremony

Book Now